Table 1 Patients’ and primary tumor’s characteristics
From: Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
Total | 48a |
Mean age, years (SD) | 58.5 (±11.0) |
Range | 36-75 |
Tumor size | |
 pT1a-c | 14 (29.2%) |
 pT2-4 | 34 (70.8%) |
Lymph node status | Â |
 Node negative | 12 (25.0%) |
 Node positive (pN1-3) | 35 (72.9%) |
 pNx | 1 (2.1%) |
Grading | |
 G1-2 | 27 (56.2%) |
 G3 | 21 (43.8%) |
Estrogen receptor status b | |
 ER positive | 30 (62.5%) |
 ER negative | 18 (37.5%) |
Progesterone receptor statusc | |
 PR positive | 25 (52.1%) |
 PR negative | 23 (47.9%) |
HER2 status | |
 negative | 36 (75.0%) |
 positive | 11 (22.9%) |
 unknown | 1 (2.1%) |
Menopausal status | |
 Premenopausal | 15 (31.3%) |
 Postmenopausal | 33 (68.7%) |
Primary operation | |
 Breast conservative | 30 (62.5%) |
 Mastectomy | 18 (37.5%) |
Systemic therapy | |
 Chemotherapy-FECd-DOCe | 21 (43.8%) |
 Chemotherapy-FEC-DOC Gemf | 27 (56.2%) |